Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis.
Saved in:
| Title: | Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis. |
|---|---|
| Authors: | Ramón-García S; Department of Microbiology, Pediatrics, Radiology and Public Health, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada. Electronic address: santiramon@unizar.es., González Del Río R; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Arenaz-Callao MP; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Boshoff HI; Tuberculosis Research Section, NIH, Bethesda, USA., Rullas J; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Anca S; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Cacho Izquierdo M; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Porras de Francisco E; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Pérez Herrán E; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Santos-Villarejo A; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Mendoza-Losana A; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Ferrer-Bazaga S; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Thompson CJ; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada., Barros Aguirre D; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain., Bates RH; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain. Electronic address: robert.h.bates@gsk.com. |
| Source: | Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2025 May; Vol. 80, pp. 101213. Date of Electronic Publication: 2025 Feb 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9815369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2084 (Electronic) Linking ISSN: 13687646 NLM ISO Abbreviation: Drug Resist Updat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40020440 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ramón-García+S%22">Ramón-García S</searchLink>; Department of Microbiology, Pediatrics, Radiology and Public Health, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada. Electronic address: santiramon@unizar.es.<br /><searchLink fieldCode="AU" term="%22González+Del+Río+R%22">González Del Río R</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Arenaz-Callao+MP%22">Arenaz-Callao MP</searchLink>; Research & Development Agency of Aragón Foundation (Fundación ARAID), Zaragoza, Spain; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Boshoff+HI%22">Boshoff HI</searchLink>; Tuberculosis Research Section, NIH, Bethesda, USA.<br /><searchLink fieldCode="AU" term="%22Rullas+J%22">Rullas J</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Anca+S%22">Anca S</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cacho+Izquierdo+M%22">Cacho Izquierdo M</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Porras+de+Francisco+E%22">Porras de Francisco E</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez+Herrán+E%22">Pérez Herrán E</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Santos-Villarejo+A%22">Santos-Villarejo A</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mendoza-Losana+A%22">Mendoza-Losana A</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ferrer-Bazaga+S%22">Ferrer-Bazaga S</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Thompson+CJ%22">Thompson CJ</searchLink>; Department of Microbiology and Immunology, Life Sciences Centre, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Barros+Aguirre+D%22">Barros Aguirre D</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bates+RH%22">Bates RH</searchLink>; Global Health Medicines R&D, GSK, Tres Cantos, Madrid, Spain. Electronic address: robert.h.bates@gsk.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229815369%22">Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy</searchLink> [Drug Resist Updat] 2025 May; Vol. 80, pp. 101213. <i>Date of Electronic Publication: </i>2025 Feb 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Churchill+Livingstone%22">Churchill Livingstone </searchLink><i>Country of Publication: </i>Scotland <i>NLM ID: </i>9815369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-2084 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213687646%22">13687646 </searchLink><i>NLM ISO Abbreviation: </i>Drug Resist Updat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40020440 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.drup.2025.101213 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101213 Titles: – TitleFull: Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ramón-García S – PersonEntity: Name: NameFull: González Del Río R – PersonEntity: Name: NameFull: Arenaz-Callao MP – PersonEntity: Name: NameFull: Boshoff HI – PersonEntity: Name: NameFull: Rullas J – PersonEntity: Name: NameFull: Anca S – PersonEntity: Name: NameFull: Cacho Izquierdo M – PersonEntity: Name: NameFull: Porras de Francisco E – PersonEntity: Name: NameFull: Pérez Herrán E – PersonEntity: Name: NameFull: Santos-Villarejo A – PersonEntity: Name: NameFull: Mendoza-Losana A – PersonEntity: Name: NameFull: Ferrer-Bazaga S – PersonEntity: Name: NameFull: Thompson CJ – PersonEntity: Name: NameFull: Barros Aguirre D – PersonEntity: Name: NameFull: Bates RH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-2084 Numbering: – Type: volume Value: 80 Titles: – TitleFull: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy Type: main |
| ResultId | 1 |